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Abstract
Background: The goal of this study was to develop and to
validate an improved isotope-dilution-liquid chromatogra-
phy-tandem mass spectrometry (LC-MS/MS) method for the
quantification of methylmalonic acid (MMA) in urine.
Methods: A previously described sample preparation pro-
tocol requires two solvent extraction steps, including evap-
oration. The first extraction is to extract the analyte from the
sample, and second occurs following derivatization of the
extract. In the method described here, the second evaporation
step was substituted by on-line solid phase extraction
employing column-switching and a permanent co-polymer
based extraction cartridge. A standard validation protocol
was applied to investigate the performance of the method.
Results: The method was found to be linear in the clinically
relevant range of concentrations (6–100 mmol/L). Total coef-
ficients of variation were below 10% and inaccuracy was
-10% for quality control samples at three concentrations.
Conclusions: By omitting one evaporation step, the semi-
automated method described in this article enables for more
convenient work-flow in the quantification of urinary MMA
compared to the previous protocol. This is of relevance for
MMA measurement in the routine clinical laboratory setting.
Validation demonstrated acceptable analytical performance.
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Increased concentrations of methylmalonic acid (MMA) are
recognized as a useful tool for the detection of cobalamin
(vitamin B12) deficiency at the tissue level (1–3). Whereas
serum cobalamin concentrations can be determined using
high throughput ligand binding methods, reliable quantifi-
cation of MMA in biological matrices requires the use of
mass spectrometric methods. Since the degree of automation
in mass spectrometric assays is limited (4), MMA quantifi-
cation is not used at present for screening of cobalamin defi-
ciency. Rather, it is typically used as a confirmatory second
line test in cases where vitamin B12 concentrations are
below 300 pg/mL.
The assessment of MMA concentrations in serum is ham-
pered by the fact that a decreased glomerular filtration rate
is associated with increased serum MMA concentrations,
irrespective of the cobalamin status (5, 6). In contrast, quan-
tification of the urinary MMA/creatinine-ratio is not subject
to interference by impaired renal function, and is thus supe-
rior to serum MMA measurements (7). Furthermore, urine
MMA concentrations are about 100-fold higher compared to
serum, which favours the robustness of analytical methods
for urine as the sample material (reference ranges (8): serum
MMA, -0.44 mmol/L wconversion of units for methylma-
lonic acid: (mmol/L)=0.118s(mg/L)x; urinary MMA/
creatinine-ratio, -3.56 mmol/mol; assuming a typical mean
urinary creatinine concentration of roughly 8.5 mmol/L, uri-
nary MMA concentrations -30 mmol/L can be considered
normal).
Gas chromatography-mass spectrometry (GC-MS) meth-
ods for the quantification of urinary MMA were introduced
in the late 1970s (9). To date, two liquid chromatography-
tandem mass spectrometry (LC-MS/MS) methods for quan-
tification of urinary MMA have been described (10, 11). Due
to the highly-specific detection principle, the need for time
consuming chromatographic separation is, in general, mini-
mized in LC-MS/MS and many laboratories are now trying
to switch MMA quantification from GC-MS to LC-MS/MS.
The methods that have been described for quantification
of urinary MMA using LC-MS/MS include a multi-step
sample preparation protocol. While the method described by
Magera et al. (11) uses solid phase extraction, the method
by Kushnir et al. (10) employs the more economic principle
of solvent extraction. This protocol includes a solvent extrac-
tion step with evaporation of the extracts both before and
after the derivatization step. The aim of our work was to
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 31.10.13 16:09
1648 Kirchhoff et al.: Quantification of urinary MMA by LC-MS/MS
Article in press - uncorrected proof
Figure 1 (A) Scheme of the on-line solid phase extraction system (AC, analytical column; W, waste; MS, mass spectrometry system).
(B) Representative MRM chromatograms obtained from a normal urine sample (MMA 9.3 mmol/L). Upper panel: dibutyl-d3-MMA. Lower
panel: dibutyl-MMA (retention time approx. 4.9 min) base-line separated from dibutyl-SA (retention time approx. 4.3 min).
Sample preparation protocol: Into 1.5 mL polypropylene cups, 50 mL of calibrator, quality control samples or human urine samples was
mixed with 50 mL of d3-MMA (8.32 mmol/L) and 25 mL of 1 M HCl. After equilibration, 1600 mL methyl tertiary butyl ether (MTBE)
was added and the cups were shaken for 10 min using a horizontal shaker. After stopping the shaking, a complete separation between
aqueous and organic phase was obtained within seconds without centrifugation, with the organic layer above the aqueous phase. The organic
phase was transferred into a 2.0 mL polypropylene cup, which was then placed into an evaporation device, thermostated at 378C (Barkey
Vapotherm, Labortechnik Barkey, Leopoldsheim, Germany). The extract was evaporated to dryness under a flow of nitrogen. The residue
was dissolved in 50 mL of the derivatization reagent 3 N HCl/BuOH by vortex mixing. The cups were opened and placed uncapped into
a derivatization oven which was housed in a hood. Derivatization was performed at 708C for 30 min. Subsequently, 300 mL AcN/H2O (75/
25 by volume) was added to the tubes. After mixing, 100 mL of this solution were transferred into HPLC vials. On-line solid phase
extraction protocol: A Waters Oasis HLB column (25 mm, 2.1=20 mm, stationary phase: specific ratio of two monomers, hydrophilic N-
vinylpyrrolidone and lipophilic divinylbenzene; Waters, Milford, USA) was used. First 30 mL of derivatized sample extract was injected
and loaded onto the extraction column in valve position A. The mobile phase was water/methanol 90/10 (v/v), delivered at a flow rate of
4 mL/min. Potentially interfering compounds were washed into waste. In parallel, the analytical column (Waters xBridge Shield RP18,
2.1=150 mm; 3.5 mm particle size) was equilibrated with 1 g/L formic acid-acetonitrile/10 mM ammonium formiate 60/40 (v/v), delivered
at a flow rate of 0.4 mL/min. After 1 min, the switching valve was changed to position B; the extraction column was now eluted in a back-
flush mode onto the analytical column. After another 2 min, the valve was switched back to position A. During the analytical chromatography
into the mass spectrometer in position A, the extraction column was washed with acetonitrile/methanol 50/50 (v/v) at a flow rate of 4 mL/
min for 1 min and the extraction column subsequently re-equilibrated with water/methanol 90/10 (v/v). The analytical column was kept at
388C in a column oven, while the extraction column was kept at ambient temperature.
improve this previously reported process of sample prepa-
ration for quantification of urinary MMA using LC-MS/MS
by applying on-line solid phase extraction (SPE) with a
permanent extraction cartridge (a scheme of the on-line SPE
procedure is shown in Figure 1A).
We used a Waters Alliance 2795 HPLC module (Waters,
Milford, MA, USA), coupled splitless to a Micromass Quat-
tro LC tandem mass spectrometry system (Waters, Manches-
ter, UK). For on-line solid phase extraction, a SPE column
was used, together with a six-port high-pressure switching
valve. Mass spectrometric conditions are listed in the online
data supplement, Appendix 1.
Calibrators were made by diluting a stock solution of
MMA with water to obtain MMA concentrations of 101.6,
76.2, 50.8, 38.1, 25.4, 12.7, 6.4 mmol/L. We used three lev-
els of quality control samples, prepared by spiking pooled
urine from healthy volunteers. Before spiking, the MMA
concentration of this pool was determined by an independent
GC-MS method, with cross-validation by an external labo-
ratory. Target concentrations of the three quality control sam-
ples were calculated from the concentration of the pool and
from the amount of spiked MMA. Aliquots of the quality
control samples, as well as calibrators were stored at –208C.
Two urine pools were prepared for additional validation of
reproducibility in the use of the method in an epidemiolog-
ical study.
The complete sample preparation and on-line SPE proce-
dure is provided in the legend to Figure 1. The retention time
of dibutyl-MMA and the internal standard dibutyl-d3-MMA
was approximately 4.9 min after injection onto the extraction
column. The total analytical run time was 6.5 min. For quan-
tification, the peak area-ratios of the multiple reaction mon-
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Table 1 Results of the method validation study (four-fold determination of spiked quality control samples in four analytical series).
Target Found Mean Total coefficient Intra-assay
concentration, concentration accuracy of variation coefficient
mmol/L (mean), mmol/L (ns16 in (ns16 in of variation
4 series), % 4 series), % (ns4; range)
QC level 1 29.4 28.9 –2.0 8.2 5.3%–11.6%
QC level 2 80.2 73.2 –8.7 5.5 2.3%–6.7%
QC level 3 173 159 –8.3 6.0 3.0%–6.6%
itoring (MRM) trace of dibutyl-MMA and the internal
standard dibutyl-d3-MMA were assessed. No fit weighting or
axis transformation was applied.
An essential characteristic of quantification of MMA by
LC-MS/MS is the need to obtain specificity towards succinic
acid (SA) – which is isobaric with MMA and occurs natu-
rally. While Kushnir et al. report that these isobaric com-
pounds are distinguishable based on different fragmentation
patterns, we were not able to obtain differentiation by MS/
MS. Consequently, baseline chromatographic separation of
MMA from SA is required for reliable quantification of uri-
nary MMA (molecular structures of MMA, SA and d3-MMA
are shown in the data Supplement Figure 1). To verify com-
plete chromatographic separation of dibutyl-MMA from
dibutyl-SA, we analyzed pure solutions of the respective
compounds as well as a mixture of both. We were able to
demonstrate baseline separation and a representative MRM-
chromatogram is shown in Figure 1B.
To test the efficacy of the on-line solid phase extraction
protocol, derivatized samples were injected directly onto the
analytical column, and for comparison, onto the entire ana-
lytical system including the on-line solid phase extraction.
This was performed in triplicate for the three quality control
samples. We observed approximately 30% higher MRM peak
areas in the MRM trace of dibutyl-d3-MMA when applying
on-line SPE compared to direct injection of the extracts
(mean peak area of the QC samples without on-line SPE,
986 and using on-line SPE, 1271).
To study the recovery of the method, five urine samples
were spiked with a pure solution of MMA (50 mL sample
was spiked with 50 mL of a 101.6 mmol/L MMA solution)
prior to sample preparation. Comparative analyses of spiked
vs. unspiked samples demonstrated a mean recovery rate of
95.4% (range: 91.8%–97.9%).
In order to characterize the sensitivity of the analytical
system, a MMA solution with a concentration of 3.2 mmol/L
was analyzed in triplicate. A mean signal-to-noise ratio of
36:1 was found.
Ion-suppression characteristics of the method were
assessed by connecting a T-piece between the chromato-
graphic column and the ion source. Using a syringe pump,
a pure solution of dibutyl-MMA (12.7 mmol/L) was deliv-
ered at a constant flow rate (0.2 mL/min) into the T-piece.
With this post-column infusion, a baseline offset was
generated in the MRM-trace of dibutyl-MMA. We did not
observe any significant variation of this offset upon injection
of human urine samples, ruling out relevant ion suppression
by residual matrix components.
Potential carry over was excluded by injecting extracts
from the highest quality control sample in quadruplicate,
immediately followed by injection of a blank sample. The
chromatogram for this sample showed no peaks in the MRM
trace of dibutyl-MMA.
In four analytical series, applying full calibration, the
mean observed results of the three quality control samples
were compared with the expected concentrations and accu-
racy was calculated. We demonstrated mean accuracy and
coefficients of variation below 10% (Table 1). Furthermore,
we found that the coefficient of determination of the seven
calibrator samples was )0.99 in all series.
In addition, inter-assay coefficients of variation were cal-
culated for two different quality control samples which were
analyzed over a six week period in 14 series for application
of the method in an epidemiological study. These two pool
samples showed a coefficient of variation of 8.2% (mean
concentration 5.3 mmol/L) and 5.2% (mean concentration
20.0 mmol/L).
Apart from several articles which describe analysis of
underivatized MMA by LC-MS/MS using electrospray ioni-
sation in the negative mode (12, 13), the majority of pub-
lished work uses the positive mode. This may be attributed
to a rather low ion yield, using negative ionization in many
instruments including ours. In order to use the positive ioni-
sation mode, derivatization of MMA to dibutyl-MMA is
required. SPE is used in the method presented here, primarily
to protect the ion source from the aggressive derivatization
mixture and second, in order to avoid the second evaporation
step which was applied by Kushnir et al. (10) following the
derivatization step. Our modified sample preparation proto-
col realizes a time saving of more than 1 h for a batch of 50
samples when compared to the method described by Kushnir
et al.
We confirmed close agreement between the method
described here and the method described by Kushnir et al.
Ten samples analyzed by both methods showed a mean devi-
ation of 2.2%; range: –9.6% to q11.0%.
The additional analytical run time required for the auxil-
iary on-line SPE sample clean-up step is moderate with
1 min (or approx. 15% of the run-time); only one additional
isocratic pump and a switching valve is required. According
to our extensive experience with quantification of immuno-
suppressants (14), on line SPE columns made of multifunc-
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tional co-polymer are very robust and can be used for several
thousand injections.
The results of the method validation study (sensitivity, ion
suppression effects, carry over, as well as imprecision and
accuracy), qualify the assay described here as being suitable
for routine clinical application. However, when considering
that the method incorporates isotope-dilution internal stan-
dardisation, coefficients of variation above 5% are surpris-
ing; which is in qualitative agreement with previous studies
(10, 11). It may be assumed that isotope effects involved in
the processes of derivatization, ionisation, and/or fragmen-
tation could account for this observation. It has been shown
previously that LC-MS/MS may be more prone to isotope
effects than that observed in GC-MS (15).
The method was found to be convenient and robust with
the approach of on-line SPE employing column switching in
a large scale application: analysis of several hundred samples
did not lead to any visible spoiling of the ion source com-
ponents and no loss in sensitivity.
In summary, based on our results and experience, we can
recommend the improved protocol described here. Our pro-
tocol involves the first on line SPE, and omits one evapo-
ration step for the quantification of urinary MMA in the
routine clinical laboratory setting.
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